すべての画像(1)
About This Item
化学式:
RuCl3 · xH2O
CAS番号:
分子量:
207.43 (anhydrous basis)
EC Number:
MDL番号:
UNSPSCコード:
12161600
PubChem Substance ID:
NACRES:
NA.22
おすすめの製品
アプリケーション
- Photocatalytic disinfection: A study highlighted the synthesis of silver-ruthenium bimetallic zinc oxide nanocomposites using Callistemon viminalis leaf extract. These nanocomposites demonstrated effective photocatalytic disinfection properties against Escherichia coli, presenting a promising application in antimicrobial coatings (Jha et al., 2024).
- Photoelectrocatalysis for hydrogen production: RuO(2)/TiO(2) heterostructures were investigated for their potential in photoelectrocatalytic hydrogen evolution, combining experimental and theoretical approaches to highlight the efficiency of ruthenium-based materials in renewable energy technologies (Kaikhosravi et al., 2023).
- Electrochemical applications: The study explored the electrochemical properties of mixed RuOx/MnOx electrodes, prepared by thermal decomposition from different precursors, showing significant implications for their use in energy storage and conversion systems (Petrucci et al., 2022).
- Catalysis and electrocatalysis: Unprotected and interconnected Ru(0) nano-chain networks were examined for their advantages in catalysis and electrocatalysis, illustrating the benefits of unprotected surfaces for improved reaction kinetics and efficiency (Anantharaj et al., 2016).
その他情報
酸化剤による酸化反応に用いる触媒。文献。
シグナルワード
Danger
危険有害性情報
危険有害性の分類
Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B
保管分類コード
8A - Combustible corrosive hazardous materials
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
個人用保護具 (PPE)
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
84050-5G-F:
84050-BULK-F:
84050-VAR-F:
84050-50VL-S-KC:
84050-1G-F:
この製品を見ている人はこちらもチェック
P.H.J. Carlsen et al
The Journal of Organic Chemistry, 46, 3936-3936 (1981)
T. Hasegawa et al.
Chemistry Letters (Jpn), 1385-1385 (1985)
E.S. Gore
Platinum Metals Rev., 27, 111-111 (1983)
Yao Zhang et al.
European journal of medicinal chemistry, 86, 449-455 (2014-09-10)
Ruthenium-based anticancer complexes have become increasingly popular for study over the last two decades. Although ruthenium complexes are currently being investigated in clinical trials, there are still some difficulties with their delivery and associated side effects. Human serum albumin (HSA)-based
Huaiyi Huang et al.
Dalton transactions (Cambridge, England : 2003), 44(35), 15602-15610 (2015-08-08)
Ruthenium complexes have been considered as promising substitutes for cisplatin in cancer chemotherapy. However, novel ruthenium-based therapies are faced with some limitations, such as unimpressive cytotoxicity toward solid tumors. Herein, we designed and synthesized phenyl-substituted terpyridyl ruthenium(ii) complexes ([Ru(tpy)(bpy)Cl](+) (Ru1)
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）